Pharmanutra SpA

Established in 2003 and led by Chairman Andrea Lacorte and Vice Chairman Roberto Lacorte, PharmaNutra develops unique food supplements and innovative medical devices, taking care of the entire production process, from proprietary raw materials to the finished product. The effectiveness of the products is demonstrated by a number of scientific evidences, including more than 140 publications.
The Group distributes and sells in Italy and abroad. In Italy, the sales activity is carried out through a network of over 150 Scientific Sales Representatives at the service of the medical class, also dedicated to the exclusive marketing of PharmaNutra products to pharmacies throughout the country. Sales abroad are guaranteed in over 50 countries through 41 partners selected among the leading pharmaceutical companies. With its products distributed worldwide, in less than 20 years PharmaNutra has succeeded in making its mark as a leading player in the iron-based oral nutritional supplements market, where it boasts major patents linked to the Sucrosomial® Technology, and it is also considered to be one of the emerging top players in the sector of medical devices for the recovery of joint capacity.
Over the years, the Group has developed a specific strategy for the management and production of intellectual property, based on the integrated management of all components: proprietary raw materials, patents, trademarks and clinical evidence.